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1. Introduction 
In order to improve the delivery efficiency of genetic material into cells both in vitro and in 
vivo, the development of effective non viral vectors for optimized gene transfer into target 
cells has become an important objective. Non-viral vector systems in particular, such as 
cationic lipids and polymers, have been widely investigated as to their suitability as a 
delivery system [1-4]. In cell lines, non-viral gene transfer mediated by cationic lipid/DNA 
aggregates has been accomplished efficiently showing no immunogenicity and low 
cytotoxicity [5]. Unfortunately, non-viral gene transfer into primary cells is still inefficient 
and results in low transgene expression in vivo [6]. In contrast to the transfection of most cell 
lines, which can be successfully performed using a variety of methods, the introduction of 
foreign DNA into primary cells requires careful selection of the gene transfer technique. 
Whereas viral strategies are involved in immunogenic risks, non-viral methods have proved 
to be inefficient for most primary cell types. This might be due to the fact that biological 
barriers have to be overcome in order to achieve successful gene delivery.  
Therefore, knowledge about the uptake mechanism and the subsequent intracellular 
processing of non-viral gene delivery systems is important for the development of efficient 
gene delivery systems. Moreover, in understanding the internalization of particles into cells, 
distinct pathways might be targeted.  
Multiple processes are thought to be involved in the cellular internalization of particles [7], 
whereas clathrin-dependent uptake is the one which has been investigated the most. 
However, other internalization pathways such as the caveolae-dependent pathway, macro-
pinocytosis, phagocytosis and the non-clathrin-non-caveolae dependent pathway are 
possible ways for gene delivery and further processing in the cells as well [8].  
The mode of internalization may affect the kinetics of intracellular processing as well as 
transfection efficiency. Depending on the uptake mechanism a variety of obstacles could be 
the reason for low transfection efficiency. Also depending on the mode of cellular uptake, 
internalization may lead to either lysosomal degradation and digestion, recycling back to 
the membrane, transcytotic transport across the epithelial barrier or delivery to other 
compartments.  
Once having been released into the cytosol, additional barriers such as insufficient 
desaggregation of the complex, poor cytoplasmic transport, cytosolic digestion by means of 
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nucleases and finally low intra-nuclear DNA delivery have to be overcome. A promising 
strategy for increasing the efficiency of non-viral vectors is to target certain uptake 
pathways that improve the efficient delivery of particles. Such a strategy requires thorough 
investigation of the different internalization pathways and the subsequent intracellular 
events involved in each case. 
In this work we concentrate on the first and second major barrier to improved transfection 
efficiency in human primary cells. Two different cell types were chosen because of their 
relevance in cardiovascular diseases: human aortic endothelial cells (HAEC) and human 
aortic smooth muscle cells (HASMC). Both cells are involved in the unwanted re-narrowing 
(restenosis) of cardiac vessels after angioplasty and therefore are the primary targets in a 
strategy for cardiovascular gene-therapy.  
The distinct uptake mechanism of cationic lipid/DNA aggregates had to be clarified in 
order to gain knowledge about further intracellular processing and other barriers which still 
had to be overcome. To distinguish between the different endocytic pathways involved in 
lipoplex internalization of the Rhodamine-labeled DC-30 lipoplexes (Rh-DC-30), both 
general and specific inhibitors of endocytic routes were monitored in the presence of 
lipoplexes and analyzed by means of flow cytometry. Table 1 represents an overview of the 
inhibitors used. To gain more insight into the intracellular fate of lipoplexes, investigation of 
their co-localization with a variety of molecules was carried out using spectral bio-imaging.  
Transferrin alexa fluor 488 (tf) was used as a marker for clathrin-mediated uptake [9-16], 
cholera toxin B alexa fluor 488 (chltx-B) was used as marker for internalization via caveolae 
and related membrane structures [8, 17], and FITC-dextran was used as a marker for 
macropinocytosis. 
It was subsequently investigated whether the failure of the endosomal release of the 
lipoplex or the desaggregation of the complex was responsible for the low transfection 
efficiency. Therefore, plasmid DNA was additionally introduced into the cytosol by 
electroporation. 
 
Inhibitor Uptake route Reference 
Chlorpromazine (chlp) Clathrin [11] 
Methyl-ß-cyclodextrin 
(mbCD) 
Clathrin and caveolae [22-24] 
Filipin (fil) Caveolae [25-27] 
Genistein (gen) Caveolae [28] 
LY 29004 (Ly) Macropinocytosis [29, 30] 
Wortmannin (wm) Macropinocytosis [29, 30] 
Nocodazole (noco) Microtubule depolymerization [31] 
Cytochalasin-D (cch-D) Actin skeleton disruptor [8] 
Table 1. Inhibitors for the specific endocytic routes 
2. Materials 
DC-30 was purchased from Avanti Polar Lipids (Birmingham, AL, USA). The Cy-5- and Rh-
DNA Labeling Kits, Transferrin Alexa Fluor conjugate 488, Cholera Toxin Subunit B Alexa 
Fluor conjugate 488 and DAPI were purchased from Molecular Probes (Leiden, The 
Netherlands). Cells were purchased from ATCC (American Type Culture Collection), 
www.intechopen.com
Investigation of Transfection Barriers Involved in  
Non-Viral Nanoparticulate Gene Delivery in Different Cell Lines 
 
79 
Manassas, USA and pEGFP from BD Clontech Germany, Heidelberg. Unless otherwise 
stated, all other chemicals were purchased from Sigma/Fluka (Deisenhofen, Germany) and 
were of analytical grade. Additional material is described in the appropriate method section. 
3. Methods 
3.1 Cell culture 
Human vascular smooth muscle cells (HASMC) were cultivated in smooth muscle cell 
medium 2 (Promocell, Heidelberg, Germany) supplemented with 5 % (v/v) FCS and human 
aortic endothelial (HAEC) were maintained in endothelial cell medium MV (Promocell, 
Heidelberg, Germany) on 100 mm culture plates. For HAEC, tissue culture plates were first 
coated with sterile-filtered 2 % gelatine solution for 10 min and washed twice with PBS w/o 
calcium and magnesium before seeding. Cells were cultivated at 37 °C in a humidified 
atmosphere with 5 % (v/v) CO2. 
3.2 Plasmid preparation 
The plasmid pEGFP carries the green fluorescent protein coding region under the control of 
the cytomegalovirus immediate-early promoter region. It was isolated from Escherichia coli 
(Stratagene, Amsterdam, NL) with the Maxi-Prep Kit from Qiagen (Hilden, Germany). 
Isolated DNA was stored in TE buffer (100 mM NaCl, 10 mM Tris-HCl) at a concentration of 
1 mg/mL at -20 °C after its purity was verified by determining the ratio of absorbance at 
260/280 nm and by gel electrophoresis. 
3.3 DNA labeling 
Cy-5-labeled and Rh-labeled DNA was prepared as described for the Mirus Labeling Kit 
(Molecular Probes, Leiden, Netherlands). 
3.4 Lipoplex formation 
Enhanced green fluorescent plasmid pEGFP (either labeled for uptake studies or unlabeled for 
transfection studies) was mixed with DC-30® in a lipid/DNA ratio (w/w) of 5:1 according to 
the following protocol: lyophilized DC-30® was redispersed in sterile transfection medium 
(TM; 250 mM saCcharose, 25 mM NaCl) at a concentration of 1 mg/ml and incubated for 
30 min at room temperature. Plasmid DNA and the respective amount of DC-30®-dispersion 
were diluted separately into equal volumes of TM in order to achieve the desired lipoplex 
concentration in 200 µL of lipoplex preparation. The dilutions were combined discontinuously 
by pipetting the plasmid into the liposome solution, gently mixing and incubating for at least 
30 min at room temperature to allow the formation of the lipoplexes.  
3.5 In vitro transfection assay 
Cells were seeded in a 24-well cluster dish at a density of 104 cells per well 24 h prior to the 
experiments and cultivated in the appropriate growth medium with serum. After 24 h in 
culture the cells were washed with 1 ml PBS and then 400 µL growth medium containing 
serum was added to the cells. 200 µL of freshly prepared lipoplexes were added to the cells. 
After incubating for 5 h at 37 °C (5 % (v/v) CO2) the supernatants were removed and 1 ml of 
the appropriate growth medium was added to each well. Thereafter, the cells were cultured 
further for a total of 48 h at 37 °C, 5 % (v/v) CO2. In the control experiments cells were 
incubated with 200 µL culture medium or 200 µL TM and treated the same way as the 
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lipoplex samples. Analysis was carried out by means of flow cytometry (see uptake and 
FACS analysis). 
3.6 Electroporation experiments 
Cells were cultivated to 80 % confluency as described above. Every 100 mm plate was 
trypsinated with 1 mL Trypsin/EDTA for 30 s (HAEC), and 90 s (HASMC) to detach the 
cells. Trypsinization was stopped by adding 3 ml culture medium with serum. After 
washing twice with ice-cold PBS, cells were redispersed in ice-cold electroporation buffer 
(100 mM Hepes, 137 mM NaCl, 4 mM Na2HPO4, 6 mM Dextrose) at a concentration of 107 
cells/ ml. Electroporation experiments were carried out using a Gene Pulser II (BioRad 
Laboratories, Muenchen, Germany). 500 µL of cell suspension was poured in a chilled 
0,4 cm gap cuvette. After adding 20 µg DNA (1 mg/mL TE-buffer pH 7,0; Tris 10 mM, 
EDTA 1 mM) the cuvette was placed on ice and electroporated with the following settings: 
for HAEC: 350 V, 750 µF; for HASMC: 500 V, 950 µF. After the shock, the cuvette stayed on 
ice for 10 min. Then, cells were transferred into a 100 mm culture plate, (gelatine-coated 
plates for HAEC, see section “cell culture”) and incubated for 48 h at 37 °C and 5 % CO2. 
Fluorescent pictures were taken with an Axiovert S 20 (Zeiss, Jena Germany, 20x). 
As a positive control experiment, C3-Toxin plasmid was electroporated into the cells to see if 
DNA was delivered into the nucleus. Effective delivery was achieved when cells were 
rounded up and dead. 
As cells were not vital enough for FACS analysis, fluorescent and non-fluorescent cells were 
counted via “Neubauer Zählkammer”. Counting was repeated twice for every culture plate 
for at least 3 independent experiments. 
3.7 Uptake studies and FACS analysis 
Two days before the uptake experiment 10 000 HAEC and HASMC respectively were 
seeded onto a 24-well tissue culture plate. One hour before the experiment the culture 
medium was refreshed with 400 µL of cell specific medium containing 5 % FCS. Prior to the 
inhibition experiments the cells were incubated with the inhibitors (cytochalasin D (Cch-
D, 10 µM) for 120 min, chlorpromazine (chlp, 56 µM), LY29004 (ly, 50 µM), wortmannin 
(wm, 50 nM) genistein (gen, 200 µM) and nocodazole (noco, 10 µM) for 60 min, filipin (fil, 
5 µg/ml for HASMC, 10 µg/mL for HAEC) for 30 min and methyl-β-cyclodextrin (mbCD, 
164 µM) for 15 min). Subsequently, the DC-30 based lipoplexes containing Cy5-labeled 
plasmid DNA were added and the cells were incubated at 37 °C for another 60 min. Then, 
cells were washed with PBS and detached with 200 µL trypsin/EDTA (0,5 mg/mL trypsin, 
0,2 mg/mL EDTA) for 30 s (HAEC) or 90 s (HASMC) and harvested by centrifugation. The 
cell pellet was washed in one ml ice-cold PBS and resuspended again in 200 µL ice-cold PBS. 
Cell toxicity was measured by adding 2 µL 7-AAD (BD Biosciences), a fluorescent DNA-
binding dye which only penetrates dead cells. Fluorescent positive cells were analyzed with 
a FACS Calibur using Cell Quest Pro software (BD Biosciences). 10 000 cells were measured 
for each sample. GFP was measured using fluorescence channel 1 (530+/-15 nm), Rh in 
fluorescence channel 2 (585+/-21 nm), 7-AAD in fluorescence channel 3 (661+/-8 nm) and 
Cy5 in fluorescence channel 4 (> 670 nm). 
In order to determine the amount of lipoplex absorbed to the outside of the cell membrane, 
experiments were also performed at 4 °C. Furthermore, control experiments such as 
incubation only with Cy5-labeled DNA with buffer alone were performed. 
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3.8 Spectral bio-imaging 
Cells were seeded onto 12-mm coverslips in 24-well plates 2 days prior to the experiment. 
Lipoplexes were prepared using DC-30® and Rh-labeled plasmid. Cells were then washed 
twice with PBS w/o calcium and magnesium and then incubated with 400 µL medium 
containing the lipoplexes. Cells were incubated simultaneously with the markers for the 
different pathways for 30 min to 2 h (tf alexa fluor 488 (10 µg/mL), chltx-B alexa fluor 488 
(2 µg/mL) and FITC dextran 70 000, (1 µg/mL)). The amount of DNA was the same as that 
used in the uptake experiments. Prior to microscopic examination, the cells were fixed with 
4 % paraformaldehyde (500 µL, 10 min, RT) and the coverslips were mounted on glass slides 
with 3 µL MobiGlow (MoBiTec, Goettingen, Germany), an antifading substance to reduce 
photobleaching effects. 
Spectral bio-imaging was performed as described previously by Huth et al. [8] with a 
SpectraCube SD-200H system (Applied Spectral Imaging, Migdal HaEmek, Israel). An 
inverted fluorescence microscope (Axiovert S 100, Zeiss, Jena Germany) equipped with a 
high-pressure mercury lamp (HBO 100) for excitation and a triple bandpass filter set was 
used. All images were taken using a 100x/1.3 oil-immersion objective lens (Plan Neofluar, 
Zeiss, Jena, Germany). In the spectral range from 400 to 700 nm the objective lens shows 
only minimal fluctuations of transmission (85-90 %). The optical head attached to the 
microscope is composed of a Sagnac common-path interferometer and imaging optics 
including a cooled CCD camera (Hamamatsu C4880-85, Japan). Microscopic images were 
obtained with spectral bio-imaging 2.5 software (Applied Spectral Imaging). The acquisition 
time of a desired image varied from 30 to 90 s depending on the brightness of the 
fluorescence and the image size. Cells were first incubated with only one dye to get single-
colored images. For further analysis images were then transferred to the SpectraView 1.6 
software (Applied Spectral Imaging). 
4. Results  
4.1 Uptake experiments with inhibitors 
For uptake experiments studied by means of flow cytometry, DNA was labeled with Cy-5. 
Cell experiments were performed at both 37 °C and 4 °C in order to distinguish cellular up-
take from adsorption of lipoplexes to the outside of the cell membrane or their fusion with 
the cell membrane. It has been described that no energy dependent internalization process 
can take place at 4 °C [18]. As the size of the DC-30® lipoplexes was determined to be in the 
range of 300 and 500 nm [5], we assumed internalization to be an active process. The 
detection of positive fluorescent signal at 4 °C therefore refers to fusion or adsorption of 
lipoplex with the cell membrane. Fig. 1 represents the amount of fluorescent positive cells 
after one hour of incubation with lipoplexes at 37 °C.  
The corresponding transfection efficiency is listed in Table 2 and shows that despite the 
fact that uptake of lipoplexes was successful in 24 % of HAEC, less than 1 % of HAEC 
were transfected. In HASMC, uptake reached as high as 80 %, whereas transfection was 
only 2 %. 
Only 1 % of fluorescent cells were detected after incubation at 4 °C  and therefore adsorption 
to the outside of the cell membrane or fusion with the cell membrane is negligible and the 
fluorescent positive cells as seen in Fig. 1 can be considered as resulting from cellular uptake 
(internalization) of the lipoplexes. Analysis of cytotoxicity confirmed results which were 
published previously [5]. 
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Fig. 1. Cells were incubated for one hour with Cy-5 labeled lipoplexes and analyzed by 
means of flow cytometry (Fl-4 channel). Prior to the measurement, every sample was 
additionally incubated with 7-AAD to determine the amount of dead cells (Fl-3 channel). 
Error bars indicate standard deviation (n=3 in 3 independent experiments). 
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Transfection method Transfection agent 
Transfection efficiency [%] 
HAEC HASMC 
Non-viral cationic 
lipid-mediated DNA-
delivery 
DC-30 lipoplex 0,40 ± 0,02 2,01 ± 0,08 
DC-30 lipoplex + 100µM 
Chloroquine 
0,70 ± 0,02 2,74 ± 0,14 
DC-30 lipoplex + 100 µM 
Chloroquine 
0,11 ± 0,03 2,47 ± 0,22 
Electroporation DNA 43 ± 7 51 ± 8 
Table 2. Influence of transfection method on transfection efficiency   
Fig. 2 and Fig. 3 show the internalization of DC-30 lipoplexes by HAEC and HASMC in the 
presence of inhibitors of different uptake pathways. Again the incubation at 4 °C did not 
show any passive adsorption or fusion of DC-30® lipoplexes with the membrane in both cell 
types.  
As depicted in Fig. 2 A the uptake of DC-30® lipoplexes by HAEC pretreated with filipin (fil) 
was reduced by about 40 % to 60 % relative to control values. However, another caveolae-
inhibitor, genistein (gen), did not reduce lipoplex uptake significantly. Genistein affects 
tyrosine kinase [19], which associates with caveolae. In contrast, filipin affects 3-ß-
hydroxycholesterols [20] and avoids the formation of caveolin coats ab initio. Filipin seems 
to intervene at the origin of internalization whereas genistein seems to inhibit further 
processing of caveosomes after budding out of the membrane. 
The inhibitor methyl-ß-cyclodextrin (mbCD) is involved in cholesterol depletion of  
the plasma membrane and therefore influencing both cholesterol-rich domains (caveolae 
and clathrin-mediated endocytosis) and was shown to reduce lipoplex uptake significantly 
by 80 %.  
Clathrin-dependent endocytosis was analyzed with chlorpromazine (chlp) which interacts 
with clathrin-coated pits and causes their loss from the surface membrane. Uptake was 
reduced by about 25 %. Combining the clathrin and caveolae-mediated endocytosis 
inhibitors chlorpromazine and filipin leads to a comparable reduction of lipoplex uptake 
with that achieved with mbCD.  
Macropinocytosis is possibly involved in the uptake mechanism of DC-30® lipoplexes in 
HAEC. Pre-incubation with the macropinocytosis inhibitors LY29004 (Ly) and wortmannin 
(wm) only led to a significant reduction of uptake using Ly but not wortmannin.  
Nocodazol (noco) acts as an inhibitor by depolymerizing microtubules and therefore 
prevents the transport vesicle (early endosome) from fusing with the late endosome in order 
to protect the early endosome´s content from digestion and degradation in the lysosomal 
compartment. Applying this inhibitor showed a 50 % reduction in fluorescent signal. 
Incubation with cytochalasin D (Cch-D), a disrupter of the actin cytoskeleton, resulted in a 
reduction of about 10 % and did not seem to be strongly involved in the uptake or 
processing of DC-30® lipoplexes. In this context, the involvement of macropinocytosis, 
which is strongly actin dependent, and the different inhibition rates caused by LY and 
wortmannin does not clarify whether or not lipoplexes are internalized via 
macropinocytosis.  
Fig. 2 B presents data on the internalization of DC-30® lipoplexes by HASMC. Cells 
pretreated with the caveolae-blocking reagents filipin and genistein showed only a slightly 
decreased uptake of lipoplexes. In contrast, upon incubation with the clathrin inhibitor  
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Fig. 2. After pre-incubation with different inhibitors (see Table 1) (x-range), HAEC (A) and 
HASMC (B) were incubated for one hour with Cy-5 labeled DC-30® lipoplexes and analyzed 
by means of flow cytometry (Fl-4 channel). Prior to measurement, every sample was also 
incubated with 7-AAD to determine the amount of dead cells (Fl-3 channel). The 
fluorescence intensity of lipoplexes without inhibitors was set to 100%. Error bars indicate 
standard deviation (n=3 in 3 independent experiments). 
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Fig. 3. HAEC were incubated for one hour with either (A) clathrin marker tf alexa-fluor 488 
and Rh-lipoplexes or (B) caveolae marker choleratoxin-subunit B alexa-fluor 488 and Rh-
lipoplexes. After subsequent DAPI staining of the nucleus, pictures were taken by spectral 
bio-imaging. I: localization of Rho-lipoplexes; II: localization of markers; III: overlay of 
single colour images. 
chlorpromazine the highest reduction of uptake was observed (about 85 %). The same result 
could be achieved with mbCD, which is involved in both clathrin and caveolae-mediated 
pathways. Again, when combining the specific caveolae and clathrin inhibitors (chlp and 
fil), lipoplex uptake could not be further reduced. Macropinocytosis is also supposed to be 
involved in lipoplex uptake in these cells, but pre-treatment with wortmannin alone caused 
only a minor reduction (about 10 %) whereas Ly did not seem to effect the uptake 
mechanism. 
On the other hand, uptake of DC-30® lipoplexes by HASMC pre-treated with nocodazole 
was diminished by about 45 %, which shows a correlation to the clathrin-blocking reagents.  
The actin-disrupting agent Cch-D did not cause a reduction of lipoplex uptake at all.  
4.2 Microscopic uptake studies 
The results obtained with uptake studies were confirmed using spectral-bio-imaging. Cells 
were first pre-incubated with the inhibitors chlormpromazine or filipin. Therefore, the 
internalization routes were examined via co-localization studies with markers for the 
clathrin- or caveolae-dependent pathways. The DNA of the lipoplex was labeled with 
Rhodamine (Rh). Transferrin alexa-fluor 488 was used as a clathrin marker, Choleratoxin-
subunit B-Alexa Fluor 488 was a marker for internalization via caveolae-dependent 
endocytosis and FITC-dextran a marker for macropinocytosis. During preparation for the 
microscopic experiments, cells were additionally incubated with DAPI (nucleus staining) as 
a control. Co-localization of the lipoplex and pathway markers was determined by bio-
spectral-imaging.  
In HAEC after one h incubation time, co-localization of lipoplexes with tf-488 (Fig. 3A) as 
well as with chltx-B-488 (Fig. 3B) was detected which indicates uptake via clathrin- and 
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caveolae-dependent pathways. No co-localization with the macropinocytosis marker FITC-
dextran 70,000 could be shown.  
In HASMC, Rh-labeled lipoplexes only showed co-localization with tf-488 (Fig. 4), the 
marker for clathrin-dependent uptake. 
In both cases, spectral bio-imaging studies confirmed the results achieved by flow 
cytometry.  
 
cholera toxin-B alexa-fluor 488 Rh-DC-30 lipoplexe
10µm
SUN-picture
 
Fig. 4. HASMC were incubated for one hour with clathrin marker tf alexa-fluor 488 and Rh-
lipoplexes. After subsequent DAPI staining of the nucleus pictures were taken by spectral 
bio-imaging. I: localization of Rh-lipoplexes; II: localization of tf alexa-fluor 488; III: overlay 
of single colour images. 
4.3 Effects on transfection efficiency 
As cellular internalization of lipoplexes was successfully achieved in both HAEC and 
HASMC by clathrin-dependent endocytosis, which results in the transport of lipoplexes via 
endosomes (Fig. 5), further investigations examined possible barriers after uptake.  
For these experiments DNA was introduced into the cell by electroporation. With this 
method, endosomal release and disintegration of the DNA from the lipoplex are no longer 
involved. Basically, it can be determined that the introduced DNA is not degraded in the 
cytosol and is able to cross the nuclear membrane to enter the nucleus. Indeed, 
electroporation resulted in transfection efficiencies of 43 % in HAEC and 51 % in HASMC 
(Table 2, Fig. 6), indicating that transfection is restricted either by insufficient endosomal 
release or insufficient release of DNA from the lipoplex.  
To investigate insufficient endosomal release, transfection experiments with DC-30® 
lipoplexes were accomplished with HAEC and HASMC as described before [5]. 
Additionally, prior to lipoplex incubation the cells were incubated with different 
concentrations of chloroquine, which represses lysosomal degradation by increasing the pH 
[21] to facilitate endosomal escape and therefore improve transfection efficiency. Addition of 
chloroquine did not lead to an increase in transfection efficiency (Table 2). This shows no 
insufficient endosomal escape of lipoplex. 
5. Discussion 
This study demonstrates, that the development of efficient non-viral gene delivery systems  
requires better understanding of the mechanism of the delivery and of the intracellular 
processing. Endocytosis is the major pathway of entry, but the involvement of specific 
endocytic pathways is still poorly defined. This study contributes to further clarify uptake 
mechanisms and barriers in gene delivery in primary cells.  
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Fig. 5. Cartoon of the main cellular internalization routes of lipoplexes. On the left hand the 
clathrin-dependent pathway and on the right hand the caveolae-mediated uptake 
mechanisms are shown. Whereas the first pathway has been well investigated, caveolin-
mediated internalization has not been examined in detail to date. The first step in the 
clathrin-dependent pathway is the budding of clathrin-coated vesicles resulting in early or 
sorting endosomes. Recycling back to the membrane happens in recycling endosomes. Early 
endosomes transform in MVB and subsequently late endosomes are formed which end up 
as lysosomes. Active exchange between the golgi apparatus and late endosomes is known. 
Particles, internalized via caveolae from so-called caveosomes offering various processing 
possibilities such as transcytosis, cytosolic release, delivery to the ER or transport to the 
golgi apparatus.  
It showed, that poor transfection efficiency of primary human aorta and smooth muscle cells 
(HAEC and HASMC) is not due to insufficient delivery into the cell. Uptake of lipoplex 
reached 20 % in HAEC and 80 % in HASMC whereas transfection was less than 3 % in both 
cases. Furthermore, it was shown, that plasmid DNA, transferred directly into the cytosol of 
the cell by electroporation effectively transfected 40 to 50% of the cells.  These data suggest, 
that DNA, once being present in the cytosol, is able to cross the nucleolae membrane and to 
show activity.  
In the present study it was shown, that lipoplexes are partly internalized in HAEC via 
caveolae mediated endocytosis. The caveolae route is known to enable transport of 
nanoparticulate drug delivery systems into and/or through the cell without involvement of 
lysosomal compartments. In case of drugs being sensitive to acidic hydrolysis or enzymatic 
degradation, e.g., biomacromolecules such as polypetides or nucleic acids, it is important to 
avoid cellular routes that transport material to lysosomes. On the other side, uptake via  
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Fig. 6. HAEC (A) and HASMC (B) after electroporation of pEGFP and 48 h incubation. Left-
handed: brightfield; Right handed: fluorescent picture (GFP), middle position: overlay of 
pictures.  
caveolae does not automatically result in effective transfection as shown in this study. 
Although uptake in HAEC was partly achieved by the caveolae route, no transfection 
occurred. This is important to consider, because obviously it is not enough to focus the 
research on modifying particulate drug carriers, e.g., by attaching specific ligands, 
introducing surface charge or pH-sensitivity, or changing the particle size or elasticity in 
order to trigger the caveolae mediated endocytosis.  
The use of different methods (flow cytometry, spectral bio-imaging, electroporation) and 
materials (markers and inhibitors of endocytosis pathways) contributed to the evidence that  
transfection of primary human aorta endothelium and smooth muscle cells was not effective 
due to insufficient dissociation of plasmid DNA from the lipid/DNA delivery system. This 
finding is of great importance for future drug deliver development in the field of gene 
therapy.  
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7. Abbreviations 
DC-30 (DC-Chol, 3ß-[(N´,N´-Dimethylaminoethane)-carbamoyl]-cholesterol-HCl and DOPE, 
Dioleoylphosphatidylethanolamine 3/7 (w/w); EGFP, enhanced green fluorescent protein; 
HASMC, human aorta smooth muscle cells; HAEC, human aorta endothelial cells; TM, 
transfection medium; DAPI, 4’,6-Diamino-2-phenylindol-dihydrochlorid; mbCD, methyl-
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beta-cyclodextrine; chlp, chlorpromazine; chtx-B, cholera toxin subunit B; tf, human 
transferrin; wm, wortmannin; gen, genistein; fil, filipin; noco, nocodazole; Ly, Ly294002 ; Rh, 
Rhodamine; cch-D, cytochalasin-D; ctrl, control; 7-AAD, 7-Amino-actinomycin 
8. References 
[1] K. Lundstrom, T. Boulikas, Viral and non-viral vectors in gene therapy: technology 
development and clinical trials, Technol Cancer Res Treat 2 (2003) 471-486. 
[2] M. Thomas, A.M. Klibanov, Non-viral gene therapy: polycation-mediated DNA 
delivery, Appl Microbiol Biotechnol 62 (2003) 27-34. 
[3] R.I. Zhdanov, O.V. Podobed, V.V. Vlassov, Cationic lipid-DNA complexes (lipoplexes) 
for gene transfer and therapy, Bioelectrochemistry 58 (2002) 53-64. 
[4] H. Boulaiz, J.A. Marchal, J. Prados, C. Melguizo, A. Aranega, Non-viral and viral vectors 
for gene therapy, Cell Mol Biol (Noisy-le-grand) 51 (2005) 3-22. 
[5] K. Kiefer, J. Clement, P. Garidel, R. Peschka-Süss, Transfection efficiency and cytotoxicity 
of nonviral gene transfer reagents in human smooth muscle and endothelial cells, 
Pharm Res 21 (2004) 1009-1017. 
[6] O. Gresch, F.B. Engel, D. Nesic, T.T. Tran, H.M. England, E.S. Hickman, I. Korner, L. 
Gan, S. Chen, S. Castro-Obregon, R. Hammermann, J. Wolf, H. Muller-Hartmann, 
M. Nix, G. Siebenkotten, G. Kraus, K. Lun, New non-viral method for gene transfer 
into primary cells, Methods 33 (2004) 151-163. 
[7] M.B. Bally, P. Harvie, F.M. Wong, S. Kong, E.K. Wasan, D.L. Reimer, Biological barriers 
to cellular delivery of lipid-based DNA carriers, Adv Drug Deliv Rev 38 (1999) 291-
315. 
[8] U.S. Huth, R. Schubert, R. Peschka-Süss, Investigating the uptake and intracellular fate 
of pH-sensitive liposomes by flow cytometry and spectral bio-imaging, J Control 
Release 110 (2006) 490-504. 
[9] S. Rothenberger, B.J. Iacopetta, L.C. Kuhn, Endocytosis of the transferrin receptor 
requires the cytoplasmic domain but not its phosphorylation site, Cell 49 (1987) 
423-431. 
[10] I. Killisch, P. Steinlein, K. Romisch, R. Hollinshead, H. Beug, G. Griffiths, 
Characterization of early and late endocytic compartments of the transferrin cycle. 
Transferrin receptor antibody blocks erythroid differentiation by trapping the 
receptor in the early endosome, J Cell Sci 103 (1992) 211-232. 
[11] L.H. Wang, K.G. Rothberg, R.G. Anderson, Mis-assembly of clathrin lattices on 
endosomes reveals a regulatory switch for coated pit formation, J Cell Biol 123 
(1993) 1107-1117. 
[12] Y. Shitara, Y. Kato, Y. Sugiyama, Effect of brefeldin A and lysosomotropic reagents on 
intracellular trafficking of epidermal growth factor and transferrin in Madin-Darby 
canine kidney epithelial cells, J Control Release 55 (1998) 35-43. 
[13] L. Pelkmans, J. Kartenbeck, A. Helenius, Caveolar endocytosis of simian virus 40 
reveals a new two-step vesicular-transport pathway to the ER, Nat Cell Biol 3 
(2001) 473-483. 
[14] A. Lakkaraju, Y.E. Rahman, J.M. Dubinsky, Low-density lipoprotein receptor-related 
protein mediates the endocytosis of anionic liposomes in neurons, J Biol Chem 277 
(2002) 15085-15092. 
www.intechopen.com
 Non-Viral Gene Therapy 
 
90
[15] M. Karin, B. Mintz, Receptor-mediated endocytosis of transferrin in developmentally 
totipotent mouse teratocarcinoma stem cells, J Biol Chem 256 (1981) 3245-3252. 
[16] I. Killisch, P. Steinlein, K. Romisch, R. Hollinshead, H. Beug, G. Griffiths, 
Characterization of early and late endocytic compartments of the transferrin cycle. 
Transferrin receptor antibody blocks erythroid differentiation by trapping the 
receptor in the early endosome, J Cell Sci 103 ( Pt 1) (1992) 211-232. 
[17] K. Sandvig, B. van Deurs, Membrane traffic exploited by protein toxins, Annu Rev Cell 
Dev Biol 18 (2002) 1-24. 
[18] S. Kessner, A. Krause, U. Rothe, G. Bendas, Investigation of the cellular uptake of E-
Selectin-targeted immunoliposomes by activated human endothelial cells, Biochim 
Biophys Acta 1514 (2001) 177-190. 
[19] R.G. Parton, B. Joggerst, K. Simons, Regulated internalization of caveolae, J Cell Biol 
127 (1994) 1199-1215. 
[20] K. Simons, E. Ikonen, Functional rafts in cell membranes, Nature 434 (1997) 569-572. 
[21] W.T. Godbey, K.K. Wu, A.G. Mikos, Tracking the intracellular path of 
poly(ethylenimine)/DNA complexes for gene delivery, Proc Natl Acad Sci U S A 96 
(1999) 5177-5181. 
[22] S.K. Rodal, G. Skretting, O. Garred, F. Vilhardt, B. van Deurs, K. Sandvig, Extraction of 
cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated 
endocytic vesicles, Mol Biol Cell 10 (1999) 961-974. 
[23] A. Subtil, I. Gaidarov, K. Kobylarz, M.A. Lampson, J.H. Keen, T.E. McGraw, Acute 
cholesterol depletion inhibits clathrin-coated pit budding, Proc Natl Acad Sci U S A 
96 (1999) 6775-6780. 
[24] P. Thomsen, K. Roepstorff, M. Stahlhut, B. van Deurs, Caveolae are highly immobile 
plasma membrane microdomains, which are not involved in constitutive endocytic 
trafficking, Mol Biol Cell 13 (2002) 238-250. 
[25] R.M. Pelletier, M.L. Vitale, Filipin vs enzymatic localization of cholesterol in guinea 
pig, mink, and mallard duck testicular cells, J Histochem Cytochem 42 (1994) 1539-
1554. 
[26] P.A. Orlandi, P.H. Fishman, Filipin-dependent inhibition of cholera toxin: evidence for 
toxin internalization and activation through caveolae-like domains, J Cell Biol 141 
(1998) 905-915. 
[27] J.E. Schnitzer, P. Oh, E. Pinney, J. Allard, Filipin-sensitive caveolae-mediated transport 
in endothelium: reduced transcytosis, scavenger endocytosis, and capillary 
permeability of select macromolecules, J Cell Biol 127 (1994) 1217-1232. 
[28] L. Pelkmans, D. Puntener, A. Helenius, Local actin polymerization and dynamin 
recruitment in SV40-induced internalization of caveolae, Science 296 (2002) 535-539. 
[29] U. Huth, A. Wieschollek, Y. Garini, R. Schubert, R. Peschka-Süss, Fourier transformed 
spectral bio-imaging for studying the intracellular fate of liposomes, Cytometry A 
57 (2004) 10-21. 
[30] N. Araki, M.T. Johnson, J.A. Swanson, A role for phosphoinositide 3-kinase in the 
completion of macropinocytosis and phagocytosis by macrophages, J Cell Biol 135 
(1996) 1249-1260. 
[31] R.B. Kelly, Microtubules, membrane traffic, and cell organization, Cell 61 (1990) 5-7. 
www.intechopen.com
Non-Viral Gene Therapy
Edited by Prof. Xubo Yuan
ISBN 978-953-307-538-9
Hard cover, 696 pages
Publisher InTech
Published online 07, November, 2011
Published in print edition November, 2011
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
This book focuses on recent advancement of gene delivery systems research. With the multidisciplinary
contribution in gene delivery, the book covers several aspects in the gene therapy development: various gene
delivery systems, methods to enhance delivery, materials with modification and multifunction for the tumor or
tissue targeting. This book will help molecular biologists gain a basic knowledge of gene delivery vehicles,
while drug delivery scientist will better understand DNA, molecular biology, and DNA manipulation.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Stefanie Ha ̈fele and Regine Su ̈ss (2011). Investigation of Transfection Barriers Involved in Non-Viral
Nanoparticulate Gene Delivery in Different Cell Lines, Non-Viral Gene Therapy, Prof. Xubo Yuan (Ed.), ISBN:
978-953-307-538-9, InTech, Available from: http://www.intechopen.com/books/non-viral-gene-
therapy/investigation-of-transfection-barriers-involved-in-non-viral-nanoparticulate-gene-delivery-in-differ
© 2011 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
